Biotricity Inc BTCY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BTCY is a good fit for your portfolio.
News
-
LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
-
Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Biotricity Announces Accelerated Path to EBITDA Positive
-
Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
-
Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
Trading Information
- Previous Close Price
- $0.77
- Day Range
- $0.75–0.79
- 52-Week Range
- $0.70–2.98
- Bid/Ask
- $0.74 / $0.80
- Market Cap
- $16.23 Mil
- Volume/Avg
- 23,095 / 66,483
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.56
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 55
- Website
- https://www.biotricity.com
Valuation
|
Metric
|
BTCY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.56 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BTCY
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.20 |
Interest Coverage | −1.71 |
Quick Ratio
BTCY
Profitability
|
Metric
|
BTCY
|
|---|---|
Return on Assets (Normalized) | −211.57% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BTCY
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Ctxbhnhfh | Clpqrq | $183.1 Bil | |||
| Stryker Corp
SYK
| Mbzclmqby | Lfm | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Tmnccklx | Sbdckp | $110.1 Bil | |||
| Medtronic PLC
MDT
| Sprcqzqy | Gfcfw | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Bxvbvczyd | Rhlmv | $37.6 Bil | |||
| DexCom Inc
DXCM
| Tcgnlphy | Blxbk | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Nylrfmyjx | Hplwccf | $24.1 Bil | |||
| Steris PLC
STE
| Qhdhyllw | Kjspbw | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Ffcncdygb | Drbgw | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Vwkfcmylf | Mnmqn | $16.6 Bil |